Publications by authors named "Thomas E Gwise"

Claim this Profile
F
FDA Analysis of Ineligibility for Acute Myeloid Leukemia Clinical Trials by Race and Ethnicity.
Dianne Pulte, Laura Fernandes, Guo Wei, Ashley Woods, Kelly J Norsworthy, Thomas E Gwise

Clin Lymphoma Myeloma Leuk· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses.
Kelly J Norsworthy, Xin Gao, Chia-Wen Ko, E Dianne Pulte, Jiaxi Zhou, Thomas E Gwise

J Clin Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of Similarity Margin in Comparative Clinical Studies to Support the Development of Biosimilar Products of Neupogen (Filgrastim, Granulocyte Colony-Stimulating Factor [G-CSF]).
Lei Nie, Donna Przepiorka, Albert Deisseroth, Rajeshwari Sridhara, Thomas E Gwise

BioDrugs· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis